2018 Program

 

Global Cardio-Oncology Summit 2018

 

For your convenience, you may also print this program.

 

Thursday, September 27, 2018

7:00 a.m. – 7:00 p.m.

TimeTopicLocation / Speaker
7:00 - 8:00Breakfast (provided) & Registration
8:00 - 8:15GCOS 2018 Welcome & IntroductionCo-Chairs: Dr. Michael Fradley & Dr. Roohi Ismail-Khan
Session 1: Opening Plenary Lecture and Patient Perspective
Chairs: Dr. Jean-Bernard Durand & Dr. Zaza Iakobishvili
8:15 - 8:45Plenary Lecture: Cardio-Oncology Historical Perspective: Past, Present, FutureDr. Susan Dent
Professor of Medicine, Associate Director of Breast Cancer Research and Co-Director of Cardio-Oncology, Duke University, Durham, NC, USA; Founder & Past-President, Canadian Cardiac Oncology Network
8:45 - 9:15Patient PerspectiveMs. Abby Jones &
Ms. Nancy Smith
9:15 - 9:30Discussion
9:30 - 9:50Break with Snacks
Session 2: New and Emerging Issues in Cardiotoxicity
Chairs: Dr. Javier Pinilla-Ibarz & Dr. John Groarke
9:50 - 10:10Modern Treatments for Breast Cancer: From Anthracyclines to CD4/6 InhibitorsDr. Roohi Ismail Khan
Co-Director, Cardio-Oncology Program, Associate Member, Department of Breast Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA
10:10 - 10:30Cardiovascular Safety of Proteasome Inhibitors and Immunomodulatory Drugs for the Treatment of Multiple MyelomaDr. Sagar Lonial
Professor and Chair, Department of Hematology and Medical Oncology, Chief Medical Officer, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
10:30 - 10:50Cardiotoxicities of Tyrosine Kinase Inhibitors to Treat CML and CLL: Heart Attacks, Strokes and Atrial Fibrillation Oh My! Dr. Michael Mauro
Leader, Myeloproliferative Neoplasms Program, Leukemia Service, Professor of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
10:50 - 11:00Case Presentations:
Challenges in the diagnosis and management of treatment-emergent cardiotoxicity
Dr. Isaac Rhea & Dr. Li Ling Tan
11:00 - 11:20Panel Discussion and Questions
Session 3: Plenary Lecture
Chairs: Dr. Javid Moslehi & Dr. Susannah Stanway
11:20 - 12:00The Role of Social Media in Promoting the Field of Cardio-Oncology with Tweeting Workshop and Audience ParticipationDr. Naveen Pemmaraju
Associate Professor, Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA
12:00 - 12:15Questions
12:15 - 1:30Lunch (provided)
Session 4: Cardiovascular Toxicity Prevention and Treatment in Special Populations
Chairs: Dr. Gregory Armstrong & Dr. Sebastian Szmit
1:30 - 1:50Unique Cardiovascular Issues Facing Paediatric Cancer SurvivorsDr. Paul Nathan
Director, Aftercare Program and Staff Oncologist, Hospital for Sick Children; Professor of Pediatrics and Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
1:50 - 2:10Cardiovascular Considerations in the Geriatric Patient with CancerDr. Martine Extermann
Professor of Oncology and Medicine, University of South Florida; Program Leader, Senior Adult Oncology Program, Moffitt Cancer Center and Research Institute, Tampa, FL, USA
2:10 - 2:30Minimizing Cardiovascular Complications in Patients with High Cancer Risk Genetic Syndromes (BRCA, Li Fraumeni Syndrome)Dr. Kathryn Ruddy
Consultant, Associate Professor of Oncology, Director of Cancer Survivorship, Department of Oncology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
2:30 - 2:40Case Presentations:
Can Risk Factor Modification Impact the Development of Cardiotoxicity?
Dr. Merna Armanious & Dr. Sara Dost
2:40 - 3:00Panel Discussion
3:00 - 3:30Break with Snacks
Session 5: Keynote Debate
Moderator: Dr. Margot Davis
3:30 - 4:15Should Direct Oral Anticoagulants Be Utilized in Cancer Patients to Prevent Thrombosis?
10-minute presentations with 5 minutes of rebuttal; 15 minutes of questions
YES: Dr. Chiara Melloni
Associate Professor of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA

NO: Dr. Kristen Sanfilippo
Assistant Professor, Department of Medicine, Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA
Session 6: Young Investigator Competition
Chair: Dr. Bonnie Ky
Judges: Dr. Anne Blaes, Dr. Chau Dang & Dr. Carlo Tocchetti
4:15 - 4:30Global Longitudinal Strain and Myocarditis with Immune Checkpoint Inhibitors
5 minute discussion
Dr. Magid Awadalla
Cardiac Imaging Research Fellow,
Massachusetts General Hospital,
Harvard Medical School
Boston, MA, USA
4:30 - 4:45Prospective Study of Cardiac Events During
Proteasome Therapy for Relapsed Multiple Myeloma
5 minute discussion
Dr. Cherie Dahm
Internal Medicine Resident,
Vanderbilt University Medical Center,
Nashville, TN, USA
4:45 - 5:00A Diagnostic Score of Cardiac Involvement in AL
Amyloidosis
5 minute discussion
Dr. Martin Nicol
Cardiology Resident,
Lariboisiere Hospital,
Paris Diderot Université
Paris, France
Thomas Force Leadership in Cardio-Oncology Lecture
Introduction by Dr. Susan Dent
5:00-5:30Dr. Daniela Cardinale
Director, Cardio-Oncology Unit, European Institute of Oncology, Milan, Italy
5:30 - 7:00Poster Reception
With Wine & Light Appetizers
7:30 - 10:00GCOS 2018 Conference Dinner
Tampa Club (separate registration required)

 

Friday, September 28, 2018

7:30 a.m. – 5:00 p.m.

TimeTopicLocation / Speaker
7:30 - 8:00Breakfast (provided)
8:00 - 8:10Opening Remarks and Day 1 OverviewCo-Chairs:
Dr. Michael Fradley & Dr. Roohi Ismail-Khan
8:10 - 8:15Announcement of the Young Investigator Award WinnerDr. Bonnie Ky
Session 7: Plenary Lecture
Chairs: Dr. Alain Cohen-Solal & Dr. Christine Simmons
8:15 - 9:00Reconciling Guidelines, Recommendations and Consensus Statements to Provide Optimal Cardio-Oncology CareDr. Saro Armenian
Associate Professor, Department of Paediatrics and Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Session 8: Malignancies with a Direct Effect on the Heart
Chairs: Dr. Negar Mousavi & Dr. Kenneth Shain
9:00 - 9:20Amyloidosis: Challenges in Diagnosis and ManagementDr. Ronald Witteles
Co-Director, Stanford Amyloid Center, Director, Internal Medicine Residency Program, Associate Professor of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA
9:20 - 9:40Cardiovascular Issues Due to Carcinoid and Other Neuroendocrine TumorsDr. Jonathan Strosberg
Section Head, Neuroendocrine Division, Associate Professor, Moffitt Cancer Center and Research Institute, Tampa, FL, USA
9:40 - 10:00Cardiac Tumors: Clinical and Imaging Evalution of Benign and Malignant LesionsDr. W. Gregory Hundley
Program Director, Cardiovascular Imaging Training Program, Professor of Cardiology and Radiology, Wake Forest School of Medicine, Baptist Health, Winston-Salem, NS, USA
10:00 - 10:10Case Presentations:
The role of a multidisciplinary approach in the diagnosis and management of malignancies affecting the heart
Dr. Rachel Harris & Dr. Katie Zhang
10:10 - 10:25Panel Discussion and Questions
10:25 - 10:45Break with Snacks
Session 9: Immunotherapy and Associated Cardiotoxicity
Chairs: Dr. Alexander Lyon & Dr. Frederick Locke
10:45 - 11:05The Rapidly Evolving Field of Immunotherapy to Treat Malignancy: From Checkpoint Inhibitors to CAR-TDr. Nikhil Khushalani
Vice-Chair and Associate Member, Department of Cutaneous Oncology, Moffitt Cancer Center; Associate Professor, Morsani College of Medicine, University of South Florida, Tampa, FL, USA
11:05 - 11:25Immunotherapy Associated with Cardiotoxicity: Pathophysiology, Detection and Treatment StrategiesDr. Tomas Neilan
Associate Professor of Medicine, Harvard Medical School; Director, Cardio-oncology Program, Co-Director, Cardiac MR PET CT Program, Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA
11:25 - 11:30Case Presentation:
Can we identify those at risk for immunotherapy associated cardiovascular dysfunction?
Dr. Saad Mahmood
11:30 - 11:45Panel Discussion and Questions
11:45 - 1:00Lunch (provided)
Session 10: Keynote Debate
Moderator: Dr. Christine Brezden-Masley
1:00 - 1:45Are We Too Focused on the QT Interval with Oncology Treatments?
10-minute presentations with 5 minutes for rebuttal and 15 minutes of questions
YES: Dr. Michael Fradley
Director, Cardio-Oncology Program, Moffitt Cancer Center and Research Institute; Associate Professor of Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA

NO: Dr. Daniel Lenihan
Director, Cardio-Oncology Center of Excellence, Professor of Medicine, Washington University, St. Louis, MO, USA
Session 11: Imaging and Research Breakout Sessions
Track 1: Advanced Cardiovascular Imaging Techniques for Cardio-Oncology
Chairs: Dr. Juan Carlos Plana & Dr. Jennifer Liu
1:45 - 2:05The Role of CMR in the Evaluation and Management of the Cardio-Oncology PatientDr. Dinesh Thavendiranathan
Director, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital; Associate Professor of Medicine, University of Toronto, Toronto, ON, Canada
2:05 - 2:25Echocardiography in Cardio-Oncology: Strain, 3D Imaging and DisatologyDr. Aarti Patel
Director, Advanced Cardiovascular Imaging Fellowship, Assistant Professor of Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA
2:25 - 3:00Techniques in Imaging WorkshopDrs. Eric Harrison, Jennifer Liu, Aarti Patel, Juan Carlo Plana & Dinesh Thavendiranathan
Track 2: Cardio-Oncology Research and Investigation
Chairs: Dr. Samuel Wickline & Dr. Daniela Cardinale
1:45 - 2:00Genomics and Personalized Medicine to Identify Those at Risk for CardiotoxicityDr. Howard McLeod
Medical Director, DeBartolo Family Personalized Medicine Institute; Chair, Department of Individualized Cancer Management; Senior Member, Division of Population Sciences, Moffitt Cancer Center and Research Institute, Tampa, FL, USA
2:00 - 2:15Incorporating Cardio-Oncology in Clinical Trial DesignDr. Laleh Amiri-Kordestani
Associate Director and Cardio-oncology Liaison, Division of Oncology Products 1, Office of Hematology Oncology Products, Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA
2:15 - 2:30Year in Review: Top Basic/Translational Research Studies in Cardio-OncologyDr. Bonnie Ky
Director, Penn Cardio-Oncology Research Program and Penn Center for Quantitative Echocardiography, Assistant Professor of Medicine and Epidemiology, Division of Cardiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
2:30 - 2:45Year in Review: Top Clinical Research Studies in Cardio-OncologyDr. Ana Barac
Director, Cardio-Oncology Program, Staff Cardiologist, MedStar Washington Hospital Center Heart and Vascular Institute; Associate Professor of Medicine and Oncology, Georgetown University School of Medicine, Washington, DC, USA
2:45 - 3:00Panel Discussion and Questions
3:00 - 3:15Break with Snacks
Session 12: How to Develop A Complete Cardio-Oncology Service
Chairs: Dr. Joseph Carver & Dr. Joerg Herrmann
3:15 - 3:30Developing a Cardio-Oncology Program in the CommunityDr. Richard Chazal
Past President, American College of Cardiology; Medical Director, Heart and Vascular Institute, Lee Health, Fort Myers, FL, USA
3:30 - 3:45Developing a Cardio-Oncology Program in an Academic EnvironmentDr. Alexander Lyon
President, British Cardio-Oncology Society; Senior Lecturer in Cardiology, Imperial College London; Consultant Cardiologist and Clinical Lead for Cardio-Oncology Services, Royal Brompton Hospital, London, United Kingdom
3:45 - 4:00Developing a Formalized Cardio-Oncology Fellowship and Educational CurriculumDr. Javid Moslehi
Director, Vanderbilt Cardio-Oncology Program, Assistant Professor of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
4:00 - 4:15The Role of Nursing in Cardio-OncologyDr. Anecita Fadol
Associate Professor, Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Natalee Roper
Clinical Nurse and Cardio-Oncology Program Nurse Coordinator, Moffitt Cancer Center and Research Institute, Tampa, FL, USA
4:15 - 4:30Cardio-Oncology Programs: An International PerspectiveDr. Ludhmila Hajjar
Director, Cancer ICU and Division of Cardio-oncology, Cancer Institute, University of São Paulo (USP). Associate Professor, Department of Cardiopneumology, Instituto do Coração (InCor), Hospital das Clínicas, USP. Director, InCor, USP. Director, Cardiology ICU and Heart Failure Unit. Director, Surgical ICU, InCor-USP, São Paulo, Brazil.
4:30 - 4:45Panel Discussion and Questions
4:45 - 5:00Closing Remarks & AdjournCo-Chairs:
Dr. Michael Fradley & Dr. Roohi Ismail-Khan

 

For your convenience, you may also print this program.